Indole RSK inhibitors. Part 1: Discovery and initial SAR

Abstract A series of inhibitors for the 90 kDa ribosomal S6 kinase (RSK) based on an 1-oxo-2,3,4,5-tetrahydro-1 H -[1,4]diazepino[1,2- a ]indole-8-carboxamide scaffold were identified through high throughput screening. An RSK crystal structure and exploratory SAR were used to define the series pharmacophore. Compounds with good cell potency, such as compounds 43 , 44 , and 55 were identified, and form the basis for subsequent kinase selectivity optimization.